Summary:
Stanford University is conducting a research study looking at the effect of an insulin-sensitizing drug on treatment for depression.
Qualified Participants Must:
• Have non-remitted depressive symptoms (either unipolar or bipolar depression are OK)
•
Be between 20 and 65 years of age
•
Not currently be diagnosed with diabetes, or taking a pre-diabetic medication
Qualified Participants May Receive:
An assessment of their cognitive and metabolic functioning and compensation for their time.